Eurocine Vaccines AB Share Price Nasdaq Stockholm
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- | - |
|
Sales 2022 | 0.07 0 5.83 | Sales 2023 | 0 0 0.42 | Capitalization | 90.88L 0 76Cr |
---|---|---|---|---|---|
Net income 2022 | -2Cr - -166.61Cr | Net income 2023 | -1.8Cr - -149.95Cr | EV / Sales 2022 | 11,92,26,800 x |
Net cash position 2022 | 1.42Cr 0 118.59Cr | Net cash position 2023 | 10.43L 0 8.69Cr | EV / Sales 2023 | 1,60,89,86,800 x |
P/E ratio 2022 |
-0.93
x | P/E ratio 2023 |
-0.41
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 7.48% |
1st Jan change | Capi. | |
---|---|---|
+38.65% | 3.91TCr | |
-8.62% | 3.88TCr | |
+26.95% | 3.12TCr | |
+10.74% | 2.59TCr | |
-13.50% | 2.58TCr | |
+44.87% | 1.41TCr | |
+34.36% | 1.31TCr | |
-7.14% | 1.13TCr | |
-12.61% | 1.07TCr |